These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15463658)

  • 1. Anti-malarial antibodies in twins: reply.
    Troye-Blomberg M; Perlmann P
    Parasitol Today; 1993 Jan; 9(1):18. PubMed ID: 15463658
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-malarial antibodies in twins.
    Taylor-Robinson AW; Phillips RS
    Parasitol Today; 1993 Jan; 9(1):1-2. PubMed ID: 15463652
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic regulation of human anti-malarial antibodies in twins.
    Sjöberg K; Lepers JP; Raharimalala L; Larsson A; Olerup O; Marbiah NT; Troye-Blomberg M; Perlmann P
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2101-4. PubMed ID: 1549568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cerebral malaria: characterization of malarial antibodies in cerebrospinal fluid.
    Mitra S; Ravindran B; Das BK; Das RK; Das PK; Rath RN
    Clin Exp Immunol; 1991 Oct; 86(1):19-21. PubMed ID: 1914232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity as a predictor of anti-malarial treatment failure: a systematic review.
    O'Flaherty K; Maguire J; Simpson JA; Fowkes FJI
    Malar J; 2017 Apr; 16(1):158. PubMed ID: 28427418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogenicity of malarial antigen obtained from infected human placenta.
    Williams AI; Ibeziako PA
    Afr J Med Med Sci; 1982 Sep; 11(3):117-21. PubMed ID: 6307027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early hyperreactive malarial splenomegaly and risk factors for evolution into the full-blown syndrome: a single-centre, retrospective, longitudinal study.
    Bisoffi Z; Leoni S; Buonfrate D; Lodesani C; Eseme FE; Monteiro GB; Marocco S; Guerriero M
    Malar J; 2015 Dec; 14():487. PubMed ID: 26626013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring anti-M antibodies in one member of fraternal twins.
    KUHNS WJ
    Transfusion; 1962; 2():58-60. PubMed ID: 14460353
    [No Abstract]   [Full Text] [Related]  

  • 9. Malarial antibodies in Auckland blood donors.
    Davidson N; Woodfield G; Henry S
    N Z Med J; 1999 May; 112(1088):181-3. PubMed ID: 10391642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyper-reactive malarial splenomegaly].
    Maazoun F; Deschamps O; Barros-Kogel E; Ngwem E; Fauchet N; Buffet P; Froissart A
    Rev Med Interne; 2015 Nov; 36(11):753-9. PubMed ID: 26119345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of conception of twin pregnancies: willingness to reply to survey items and comparison of survey data to hospital records.
    van Beijsterveldt CE; Hoekstra C; Schats R; Montgomery GW; Willemsen G; Boomsma DI
    Twin Res Hum Genet; 2008 Jun; 11(3):349-51. PubMed ID: 18498213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-M antibodies in the blood serum of 8-month-old twins].
    Nowicki S; Pniewski T; Tomczyk-Budzińska H
    Przegl Lek; 1965; 21(12):713-5. PubMed ID: 5893214
    [No Abstract]   [Full Text] [Related]  

  • 13. Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria elimination.
    Abdul-Ghani R; Basco LK; Beier JC; Mahdy MA
    Malar J; 2015 Oct; 14():413. PubMed ID: 26481312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-malarial prescription practices among children admitted to six public hospitals in Uganda from 2011 to 2013.
    Sserwanga A; Sears D; Kapella BK; Kigozi R; Rubahika D; Staedke SG; Kamya M; Yoon SS; Chang MA; Dorsey G; Mpimbaza A
    Malar J; 2015 Aug; 14():331. PubMed ID: 26306395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay.
    Linares M; Viera S; Crespo B; Franco V; Gómez-Lorenzo MG; Jiménez-Díaz MB; Angulo-Barturen Í; Sanz LM; Gamo FJ
    Malar J; 2015 Nov; 14():441. PubMed ID: 26542470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy.
    Deng X; Duffy SP; Myrand-Lapierre ME; Matthews K; Santoso AT; Du YL; Ryan KS; Ma H
    Malar J; 2015 Oct; 14():428. PubMed ID: 26520795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
    Tougan T; Toya Y; Uchihashi K; Horii T
    Malar J; 2019 Jan; 18(1):8. PubMed ID: 30642330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field study.
    Visser BJ; Meerveld-Gerrits J; Kroon D; Mougoula J; Vingerling R; Bache E; Boersma J; van Vugt M; Agnandji ST; Kaur H; Grobusch MP
    Malar J; 2015 Jul; 14():273. PubMed ID: 26169915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action.
    Navarro M; Castro W; Madamet M; Amalvict R; Benoit N; Pradines B
    Malar J; 2014 Dec; 13():471. PubMed ID: 25470995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
    Kim JH; Choi AR; Kim YK; Yoon S
    Biochem Biophys Res Commun; 2013 Nov; 441(3):655-60. PubMed ID: 24284282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.